IMMUNOVANT INC. - CO
29,40
07-октября-24 15:59:58
15 мин. задержка
Акции
-1,11
-3,64%
Сегодняшний диапазон
28,92 - 30,58
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Immunovant Reports Financial Results for the Quarter Ended September 30, 2021
05 ноя 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Participate in Roivant R&D Day 2021
27 сен 2021 08:00:00 Источник Nasdaq GlobeNewswire
-
Immunovant Appoints Renee Barnett as Chief Financial Officer
15 сен 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
Immunovant Reports Financial Results for the Quarter Ended June 30, 2021
09 авг 2021 06:30:00 Источник Nasdaq GlobeNewswire
-
Immunovant to Report Financial Results for Quarter Ended June 30, 2021
06 авг 2021 16:22:27 Источник Nasdaq GlobeNewswire
-
Immunovant Receives $200 Million Strategic Investment from Roivant Sciences
02 авг 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
01 июн 2021 07:31:18 Источник Nasdaq GlobeNewswire
-
Immunovant Reports Financial Results for the Quarter and Nine Months Ended December 31, 2020
16 фев 2021 08:00:04 Источник Nasdaq GlobeNewswire
-
Immunovant Announces Voluntary Pause in Clinical Dosing of IMVT-1401
02 фев 2021 06:30:00 Источник Nasdaq GlobeNewswire
-
Immunovant Appoints Rita Jain Chief Medical Officer And Provides Corporate Update
12 янв 2021 17:00:00 Источник Nasdaq GlobeNewswire